26 May 2020

The Radboud Biobank has added one new sub-biobank to the collection: HEMLYM.

The Hematology-Lymphoma Biobank plans to collect blood, saliva, serum and cell-free DNA from every lymphoma patient, in addition to the residual material available from the Pathology department (tumor tissue), the Hematology department and the Laboratory of Hematology (bone marrow, peripheral blood and tumor tissue). In recent years, much progress has been made in the knowledge surrounding the processes involved in the development and progression of lymph node cancer and the response to therapy. The aim and ambition of HEMLYM is to improve the diagnosis and treatment of patients with lymphoma.
 
  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud Biobank

Related news items


Overview of samples in storage

10 May 2021

It is possible to request an overview of the samples stored in a sub-biobank when desired.

read more

Magazine celebrating 10 years BBMRI.nl

10 May 2021

In the past 10 years, BBMRI.nl has made great progress in fulfilling its mission to maximize the use of biomaterial, images and clinical data for health research.

read more

Growth Fund invests in Health-RI proposal for health data infrastructure

10 May 2021

The Dutch Government has decided to honor Health-RI's proposal for a national health data infrastructure.

read more

GENPAD sub-biobank

10 May 2021

The GENPAD Biobank is part of the GENPAD study and contains biomaterial and clinical data from patients with peripheral arterial disease.

read more

CORONIS sub-biobank

10 May 2021

The CORONIS Biobank will focus on research into the pathophysiology of ischemic stroke after COVID-19 infection.

read more

Animation Radboud Biobank for patients

28 January 2021

The Radboud Biobank has had an animation made to inform Radboudumc visitors about the Radboud Biobank and its purpose.

read more